Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Physical Review Letters|March 16, 2007
Robust transport barriers resulting from strong Kolmogorov-Arnold-Moser stabilityI I Rypina, M G Brown, F J Beron-Vera, et al.
Neurologia (Barcelona, Spain)|June 27, 2006
[Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease]R Blesa, G García Ribas, L Galdós, et al.
Revista De Neurologia|September 24, 2016
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja]T Ayuso, M E Marzo-Sola, T Castillo-Trivino, et al.
Geophysical Research Letters|January 6, 2009
Persistent transport barrier on the West Florida ShelfM J Olascoaga, I I Rypina, M G Brown, et al.
Neurologia|April 1, 2019
Experience with tocilizumab in patients with neuromyelitis optica spectrum disordersE Carreón Guarnizo, R Hernández Clares, T Castillo Triviño, et al.
Neurologia|April 25, 2022
Experience with tocilizumab in patients with neuromyelitis optica spectrum disordersE Carreón Guarnizo, R Hernández Clares, T Castillo Triviño, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2014
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patientsM Muñoz-Culla, H Irizar, T Castillo-Triviño, et al.
Genes and Immunity|September 24, 2010
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infectionK Vandenbroeck, I Alloza, B Swaminathan, et al.
Neurologia (Barcelona, Spain)|November 15, 2011
Spanish consensus on the use of natalizumab (Tysabri(®))--2011O Fernández, J A García-Merino, R Arroyo, et al.
Neurologia (Barcelona, Spain)|December 24, 2013
Spanish consensus on the use of natalizumab (Tysabri®)-2013O Fernández, J A García-Merino, R Arroyo, et al.
Pageof 5